| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Research Center for Endocrinology and Metabolism (S.S., K.W., J.-O.J.), Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden; and Department of Clinical Chemistry and Pathobiochemistry (A.M.G.), Rheinisch-Westfalische Technische Hochschule-University Hospital, D-52057 Aachen, Germany
Address all correspondence and requests for reprints to: Stanko Skrtic, Research Center for Endocrinology and Metabolism, Endocrine Division, Gröna Stråket 8, Sahlgrenska, University Hospital, SE-413 45 Göteborg, Sweden. E-mail: stanko{at}medic.gu.se
It has been shown recently that insulin-like growth factor 1 (IGF-1) increases both DNA synthesis and hepatocyte growth factor (HGF) production in cultured hepatic stellate cells. In this study, we used selective blockers to investigate crucial signaling pathways for these effects of IGF-1 in cultured rat hepatic stellate cells.
Both LY 294002 [a phosphatidylinositol 3-kinase (PI3-K) inhibitor], and rapamycin [a blocker of activation of the serine/threonine p70 S6 kinase (p70S6K), a molecule downstream from PI3-K] completely reversed the IGF-1-induced stimulation of DNA synthesis. Mitogen-activated protein kinase (MAPK) inhibition by PD 98059 had a less pronounced suppressory effect, although the used PD 98059 dose was fully effective in inhibiting MAPK phosphorylation. Both LY 294002 and PD 98059 lowered the IGF-1-induced increase of HGF in the medium by about 40%, but LY 294002 was 10 times more potent than PD 98059. Inhibition of p70S6K activation by rapamycin blocked IGF-1-induced DNA synthesis but not the increase in HGF.
In conclusion, PI3-K (and, to some extent, MAPK) signaling pathways seem to be important for IGF-1-stimulated DNA synthesis and HGF production. DNA synthesis also seems to be dependent on rapamycin-sensitive activation of the PI3-K effector p70S6K.
This article has been cited by other articles:
![]() |
W. Boers, S. Aarrass, C. Linthorst, M. Pinzani, R. O. Elferink, and P. Bosma Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis: GREMLIN AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS J. Biol. Chem., June 16, 2006; 281(24): 16289 - 16295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gabele, S. Reif, S. Tsukada, R. Bataller, Y. Yata, T. Morris, L. W. Schrum, D. A. Brenner, and R. A. Rippe The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell Proliferation J. Biol. Chem., April 8, 2005; 280(14): 13374 - 13382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Sanz, J B Pucilowska, S Liu, C M Rodriguez-Ortigosa, P K Lund, D A Brenner, C R Fuller, J G Simmons, A Pardo, M-L Martinez-Chantar, et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury Gut, January 1, 2005; 54(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Scharf, F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demori, B. Kubler, and T. Braulke Insulin-Like Growth Factor (IGF)-Binding Protein-1 Is Highly Induced during Acute Carbon Tetrachloride Liver Injury and Potentiates the IGF-I-Stimulated Activation of Rat Hepatic Stellate Cells Endocrinology, July 1, 2004; 145(7): 3463 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, M. Bar-Eli, S. Meloche, and P. Brodt Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor: THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt AND Raf/ERK PATHWAYS TRANSMIT OPPOSING SIGNALS J. Biol. Chem., May 7, 2004; 279(19): 19683 - 19690. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |